Kringle Pharma
Manufacturing · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1-5-3 Shinsenri-Higashimachisenri Asahi ...Phone Number
+81 726418739Website
www.kringle-pharma.comRevenue
$5 MillionIndustry
About Kringle Pharma
クリングルファーマ株式会社 is a late-stage clinical trial bioventure focused on regenerative medicine, specifically targeting rare and intractable diseases. The company is developing innovative treatments using HGF protein, which has protective and regenerative properties for tissues and organs. Their research and development efforts include clinical trials for conditions such as acute spinal cord injury, vocal cord scarring, amyotrophic lateral sclerosis (ALS), and acute kidney injury. With a robust system for producing HGF protein at a pharmaceutical grade, they aim to advance the development of therapies for difficult-to-treat diseases.Explore more
SIC Code 28,283NAICS Code 32,325Show more
Kringle Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Kringle Pharma Tech Stack
A closer look at the technologies used by Kringle Pharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kringle Pharma
Sign Up For FreeTo access detailed company insights
クリングルファーマ株式会社 is a late-stage clinical trial bioventure focused on regenerative medicine, specifically targeting rare and intractable diseases. The company is developing innovative treatments using HGF protein, which has protective and regenerative properties for tissues and organs. Their research and development efforts include clinical trials for... Read More
